
The REACH octocrylene restriction is one of the most consequential chemical proposals facing the cosmetics sector in the EU. On 24 September 2025, the European Chemicals Agency (ECHA) opened a public consultation on a proposal submitted by France, through its agency ANSES, to restrict octocrylene in finished cosmetic products under Annex XVII of REACH. The proposed limit of 0.001% w/w would end the substance's practical use as a UV filter. This guide sets out what the proposal requires, who it affects, where it stands, and how manufacturers can prepare while the outcome is still being decided.
Key Takeaways
๐ France (ANSES) submitted a REACH Annex XVII restriction proposal on octocrylene; ECHA's public consultation ran from 24 September 2025 to 24 March 2026.
๐ The proposed limit is 0.001% w/w in finished cosmetic products, a level at which octocrylene no longer functions as a UV filter.
โ ๏ธ The legal basis is environmental risk to aquatic organisms under REACH, separate from the human-health safety already assessed under the EU Cosmetics Regulation.
โณ ECHA's RAC and SEAC committees are forming their opinions during 2026; a European Commission decision is expected in 2027 at the earliest, with a proposed 24-month transition.
๐ญ Sunscreens, SPF moisturisers, foundations, and lip care with SPF are most exposed, along with their formulators and importers.
๐ Reformulation and substitution decisions depend on multi-tier supplier data and substance visibility at the bill-of-materials level.
What the Octocrylene Restriction Proposal Actually Is
Octocrylene (CAS 6197-30-4, EC 228-250-8) is an organic UV filter used for UVB and short-UVA absorption and for stabilising other filters in sunscreen formulations. France prepared the restriction dossier and submitted it to ECHA on 18 July 2025, and ECHA opened the consultation on 24 September 2025 under the REACH framework.
The proposal states that octocrylene should not be placed on the market or used in finished cosmetic products at concentrations equal to or greater than 0.001% w/w. According to the official ECHA restriction record, that concentration is set low enough to end intentional use, while leaving room for trace presence as an impurity. This is a proposed restriction and carries no legal force until adopted.
The confirmed driver is environmental. ECHA classifies octocrylene as very toxic to aquatic life with long-lasting effects, and ANSES reports that more than 1,500 tonnes are used in cosmetics across Europe each year, entering wastewater and sewage sludge after application. The concern sits alongside the wider pattern of cosmetic ingredient bans reshaping the sector.
Why REACH and Not the Cosmetics Regulation
A common point of confusion is that octocrylene remains authorised for human safety while facing a near-total environmental limit. Both positions are correct because two separate frameworks apply. The EU Cosmetics Regulation (EC) No 1223/2009 governs human health and permits octocrylene as a UV filter up to 10% under Annex VI, a level the Scientific Committee on Consumer Safety assessed as safe (SCCS/1627/21).
REACH addresses risks that the Cosmetics Regulation does not, including release into the environment. That is why France routed an environmental concern through a REACH Annex XVII restriction rather than a cosmetics amendment. Manufacturers tracking REACH Annex XVII changes should treat the two regimes as parallel obligations rather than a single approval.
Dimension | EU Cosmetics Regulation 1223/2009 | Proposed REACH Annex XVII Restriction |
|---|---|---|
Concern addressed | Human health / consumer safety | Environmental risk to aquatic life |
Current status | In force | Proposed, not yet binding |
Octocrylene limit | Up to 10% (Annex VI, UV filter) | 0.001% w/w in finished cosmetics |
Assessing body | SCCS | ECHA (RAC and SEAC) |
Octocrylene concentration limits under REACH restriction and EU Cosmetics Regulation
Click on image to view full
Who Is Affected and Which Products Are in Scope
The restriction targets finished cosmetic products, as defined by the Cosmetics Regulation, so the impact reaches across formulators, brand owners, contract manufacturers, and importers placing products on the EU market. Companies managing materials and environmental compliance across a portfolio will see exposure concentrated in sun and daily-SPF categories.
Segment | Typical products in scope |
|---|---|
๐ญ Suncare | Sunscreens, after-sun with SPF, sports and sport-specific SPF |
๐ญ Daily skincare | SPF moisturisers, tinted moisturisers, primers with SPF |
๐ญ Colour cosmetics | Foundations and BB creams with SPF, SPF lip care |
๐ญ Contract manufacturing | Formulators and fillers producing SPF products for EU markets |
๐ Chemical supply | UV filter and raw-material manufacturers and distributors |
๐ Retail and import | Brands and importers placing finished products on the EU market |
Any product that relies on octocrylene for UV performance or photostability sits in scope. For consumer goods manufacturers with broad SKU counts, the first task is identifying which formulations and finished products actually contain the substance across the supply base.
Timeline and Current Status
The consultation closed on 24 March 2026. ECHA's Committee for Risk Assessment (RAC) and Committee for Socio-Economic Analysis (SEAC) advanced their restriction work on octocrylene at their March 2026 committee meetings, and their opinions are expected to conclude during 2026. Based on the ANSES statement and the European Commission's REACH Restrictions Roadmap released on 31 August 2026, a Commission decision is expected in 2027 at the earliest.
Milestone | Date / status |
|---|---|
Dossier submitted to ECHA | 18 July 2025 |
Public consultation opens | 24 September 2025 |
Public consultation closes | 24 March 2026 |
RAC and SEAC opinions | Expected during 2026 |
European Commission decision | 2027 at the earliest |
Transition period (proposed) | 24 months after entry into force |
Supply Chain and Reformulation Impact
If adopted, the restriction removes octocrylene-containing cosmetics from the EU market after the transition period. That converts a chemistry question into a supply-chain and documentation program. Reformulation requires alternative UV filters, new stability testing, and confirmation that substitutes are compliant across every jurisdiction where a product is sold, which is where expanding into new markets and maintaining EU access intersect.
The proposed 24-month transition is measured from entry into force, not from today. Industry stakeholders used the consultation to argue for a longer transition to accommodate reformulation, testing, and packaging changes, though no confirmed extended period has been set. Manufacturers that wait for the final legal text will compress reformulation into a shorter window. Firms that map exposure now, using supplier documentation collection, retain more room to act.
Compliance Risks and Market-Access Exposure
The central risk is market access. A product that still contains octocrylene above the limit after the transition would not be lawful to place on the EU market. For a global manufacturer, that means potential SKU withdrawal, reformulation cost, and customer or retailer requirements that often move ahead of the statutory deadline.
โ ๏ธ Documentation risk compounds the exposure. Proving that a reformulated product meets the limit depends on accurate supplier declarations, substance data, and evidence that can be produced on request. Treating octocrylene as part of a broader chemical and hazmat compliance program, rather than a one-off reformulation, reduces the chance of surprises during customer audits or market surveillance.
How Manufacturers Should Prepare
A proposed restriction is the right moment to build readiness while the timeline still allows it. The following steps apply whether or not the final limit matches the proposal.
๐ Identify exposure. Screen the portfolio and bills of materials to locate every formulation and finished product containing octocrylene, including private-label and contract-manufactured lines.
๐ Collect supplier data. Request current declarations from formulators and raw-material suppliers, and confirm concentration levels against the 0.001% w/w threshold.
๐ Assess substitution. Evaluate alternative UV filters for performance, photostability, and compliance in each target market.
โณ Plan for the transition. Build a reformulation and testing schedule that assumes a 24-month window from entry into force, and revise if a longer period is confirmed.
๐ Keep evidence audit-ready. Retain time-stamped declarations and substance data so compliance status can be demonstrated on demand.
This is the same discipline manufacturers are applying to parallel Annex XVII actions, such as the REACH Annex XVII formaldehyde restriction, where early substance mapping shortened the reformulation runway.
Octocrylene restriction compliance readiness workflow for cosmetics manufacturers
Click on image to view full
How AI-Native Compliance Supports Octocrylene Readiness
The operational challenge is not understanding the 0.001% limit. It is knowing, across thousands of SKUs and a multi-tier supply base, where octocrylene sits and whether supplier evidence supports each claim. That is a data problem before it is a chemistry problem.
Certivo functions as the system of record for that data. Its compliance platform connects substance-level information to specific products and bills of materials, so a restriction like this can be mapped to affected SKUs rather than researched line by line. Tracking compliance at the BOM level turns a portfolio question into a targeted list of products to reformulate.
CORA-powered regulatory intelligence adds the deterministic, traceable analysis layer. CORA is Certivo's deterministic AI compliance engine, and its process runs as a continuous loop of Capture, Analyze, Validate, Assure, and Monitor. The Monitor stage re-screens bills of materials as regulatory content changes, so a shift from proposal to adopted restriction reopens the loop automatically rather than waiting for a manual review. Because internal and customer-specific restricted-substance lists can be modelled alongside statutory rules, a company can begin screening for octocrylene as an internal watch item before the EU decision is final. This is the difference between reactive compliance and proactive compliance risk management, and it keeps evidence audit-ready across frameworks.
Executive Outlook
The REACH octocrylene restriction signals a broader direction: environmental risk, not only human safety, now drives what can be sold in the EU. A substance authorised for consumer use can still face a market-ending limit on environmental grounds, and the cosmetics sector should expect more filters and formulation ingredients to follow the same path. The proposal is not yet law, and the timeline points to a Commission decision in 2027 at the earliest, but the reformulation and evidence work required leaves little room to wait.
The manufacturers best positioned are those that can answer three questions quickly: which products contain the substance, whether supplier evidence supports each claim, and how fast a compliant reformulation can reach the market. Building that visibility now, while the outcome is still open, is the practical response to a moving regulatory picture.
To understand octocrylene exposure across products and suppliers before the final decision, request a compliance risk assessment with a Certivo compliance specialist.
Lavanya
Lavanya is an accomplished Product Compliance Engineer with over four years of expertise in global environmental and regulatory frameworks, including REACH, RoHS, Proposition 65, POPs, TSCA, PFAS, CMRT, FMD, and IMDS. A graduate in Chemical Engineering from the KLE Institute, she combines strong technical knowledge with practical compliance management skills across diverse and complex product portfolios.
She has extensive experience in product compliance engineering, ensuring that materials, components, and finished goods consistently meet evolving international regulatory requirements. Her expertise spans BOM analysis, material risk assessments, supplier declaration management, and test report validation to guarantee conformity. Lavanya also plays a key role in design-for-compliance initiatives, guiding engineering teams on regulatory considerations early in the product lifecycle to reduce risks and streamline market access.
Her contributions further extend to compliance documentation, certification readiness, and preparation of customer deliverables, ensuring transparency and accuracy for global stakeholders. She is adept at leveraging compliance tools and databases to efficiently track regulatory changes and implement proactive risk mitigation strategies.


